Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Myrobalan Therapeutics logo — Myro’s mission is to develop first-in-class and best-in-clas...

Myrobalan Therapeutics

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS disorders.

Founded 2021 United States Medford, United States 27 employees Grant Total: $24.40M Biotechnology, Health Care +1

General Information

Company Name Myrobalan Therapeutics
Founded Year 2021
Location United States Medford, United States
Employees 27
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Myrobalan Therapeutics. To contact Myrobalan Therapeutics, visit myrotx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Myrobalan Therapeutics

Myrobalan Therapeutics is a biotechnology startup founded in 2021 with the mission to develop first-in-class and best-in-class small molecule drugs for CNS disorders. The company focuses on addressing the unmet need and societal burdens posed by neurodegenerative, demyelinating, and neuropsychiatric disorders. Their recent funding round saw a $400.00K grant investment from The ALS Association on 07 February 2024. The company is headquartered in the United States. Myrobalan Therapeutics is at the forefront of developing innovative solutions for challenging CNS disorders, positioning them as an intriguing prospect for investors looking to support groundbreaking advancements in the biotechnology and healthcare sectors.

Taxonomy: biopharmaceuticals, CNS disorders, neurodegenerative diseases, demyelinating disorders, neuropsychiatric disorders, small molecule drugs, therapeutics, drug development, neurology, pharmaceutical research, medical innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $400.00K 1
The ALS Association
07 Feb 2024
Series A $24.00M 4
Cowin Venture 3E Bioventures Capital AB Magnitude Ventures Group
Cowin Venture, 3E Bioventures Capital +2
10 Jan 2024

Myrobalan Therapeutics Alternatives & Competitors

View All Alternatives
Myrobalan Therapeutics vs
XWPharma
XWPharma United States

Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other underserved CNS...

Series C
16 employees
Biotechnology, Health Care
Myrobalan Therapeutics vs
Chase Pharmaceuticals
Chase Pharmaceuticals

Pioneering advancements in neuropsychiatric treatment for a brighter future

Series B
11-50 employees
Biotechnology, Health Care
Myrobalan Therapeutics vs
Proniras Corporation
Proniras Corporation United States

Clinical-stage biotechnology developing therapeutics for the treatment of substance use & specialty...

Series B
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About Myrobalan Therapeutics

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS disorders.
Myrobalan Therapeutics was founded in 2021.
Myrobalan Therapeutics is headquartered in Medford, United States.
Myrobalan Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biopharmaceuticals, CNS disorders, neurodegenerative diseases and demyelinating disorders.
Myrobalan Therapeutics has approximately 27 employees.
Myrobalan Therapeutics has completed 2 funding rounds, raising a total of $24.40M. The latest funding stage is Grant.
Top alternatives and competitors to Myrobalan Therapeutics include XWPharma, Chase Pharmaceuticals, Proniras Corporation, Hinge Therapeutics, Angitia Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Myrobalan Therapeutics and XWPharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Myrobalan Therapeutics, https://bouncewatch.com/company/myrobalan-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes